This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lin, A. H.
Right arrow Articles by Marotti, K. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lin, A. H.
Right arrow Articles by Marotti, K. R.

 Previous Article  |  Next Article 

Antimicrob. Agents Chemother., 10 1997, 2127-2131, Vol 41, No. 10
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

The oxazolidinone eperezolid binds to the 50S ribosomal subunit and competes with binding of chloramphenicol and lincomycin

AH Lin, RW Murray, TJ Vidmar and KR Marotti
Molecular Biology Research, Pharmacia & Upjohn, Kalamazoo, Michigan 49007, USA.

The oxazolidinones are a novel class of antibiotics that act by inhibiting protein synthesis. It as been reported that the drug exerts its primary activity on the initiation phase of translation. In order to study the possibility of direct interaction between the drug and the ribosome, we have developed a binding assay using 14C-labelled eperezolid (PNU-100592; formerly U-100592). Eperezolid binds specifically to the 50S ribosomal subunit of Escherichia coli. The specific binding of eperezolid is dose dependent and is proportional to the ribosome concentrations. Scatchard analysis of the binding data reveals that the dissociation constant (Kd) is about 20 microM. The binding of eperezolid to the ribosome is competitively inhibited by chloramphenicol and lincomycin. However, unlike chloramphenicol and lincomycin, eperezolid does not inhibit the puromycin reaction, indicating that the oxazolidinones have no effect on peptidyl transferase. In addition, whereas lincomycin and, to some extent, chloramphenicol inhibit translation termination, eperezolid has no effect. Therefore, we conclude that the oxazolidinones inhibit protein synthesis by binding to the 50S ribosomal subunit at a site close to the site(s) to which chloramphenicol and lincomycin bind but that the oxazolidinones are mechanistically distinct from these two antibiotics.


This article has been cited by other articles:

  • Locke, J. B., Hilgers, M., Shaw, K. J. (2009). Novel Ribosomal Mutations in Staphylococcus aureus Strains Identified through Selection with the Oxazolidinones Linezolid and Torezolid (TR-700). Antimicrob. Agents Chemother. 53: 5265-5274 [Abstract] [Full Text]  
  • Paul-Satyaseela, M., Solanki, S. S., Sathishkumar, D., Bharani, T., Magesh, V., Rajagopal, S. (2009). In vitro antibacterial activities of a novel oxazolidinone, OCID0050. J Antimicrob Chemother 64: 797-800 [Abstract] [Full Text]  
  • LaPlante, K. L., Sakoulas, G. (2009). Evaluating Aztreonam and Ceftazidime Pharmacodynamics with Escherichia coli in Combination with Daptomycin, Linezolid, or Vancomycin in an In Vitro Pharmacodynamic Model. Antimicrob. Agents Chemother. 53: 4549-4555 [Abstract] [Full Text]  
  • Kalia, V., Miglani, R., Purnapatre, K. P., Mathur, T., Singhal, S., Khan, S., Voleti, S. R., Upadhyay, D. J., Saini, K. S., Rattan, A., Raj, V. S. (2009). Mode of Action of Ranbezolid against Staphylococci and Structural Modeling Studies of Its Interaction with Ribosomes. Antimicrob. Agents Chemother. 53: 1427-1433 [Abstract] [Full Text]  
  • Skripkin, E., McConnell, T. S., DeVito, J., Lawrence, L., Ippolito, J. A., Duffy, E. M., Sutcliffe, J., Franceschi, F. (2008). R{chi}-01, a New Family of Oxazolidinones That Overcome Ribosome-Based Linezolid Resistance. Antimicrob. Agents Chemother. 52: 3550-3557 [Abstract] [Full Text]  
  • Wilson, D. N., Schluenzen, F., Harms, J. M., Starosta, A. L., Connell, S. R., Fucini, P. (2008). The oxazolidinone antibiotics perturb the ribosomal peptidyl-transferase center and effect tRNA positioning. Proc. Natl. Acad. Sci. USA 105: 13339-13344 [Abstract] [Full Text]  
  • Besier, S., Ludwig, A., Zander, J., Brade, V., Wichelhaus, T. A. (2008). Linezolid Resistance in Staphylococcus aureus: Gene Dosage Effect, Stability, Fitness Costs, and Cross-Resistances. Antimicrob. Agents Chemother. 52: 1570-1572 [Abstract] [Full Text]  
  • Richter, E., Rusch-Gerdes, S., Hillemann, D. (2007). First Linezolid-Resistant Clinical Isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 51: 1534-1536 [Abstract] [Full Text]  
  • McKee, E. E., Ferguson, M., Bentley, A. T., Marks, T. A. (2006). Inhibition of Mammalian mitochondrial protein synthesis by oxazolidinones.. Antimicrob. Agents Chemother. 50: 2042-2049 [Abstract] [Full Text]  
  • Rucker, J. C., Hamilton, S. R., Bardenstein, D., Isada, C. M., Lee, M. S. (2006). Linezolid-associated toxic optic neuropathy. Neurology 66: 595-598 [Abstract] [Full Text]  
  • Carsenti-Dellamonica, H., Galimand, M., Vandenbos, F., Pradier, C., Roger, P. M., Dunais, B., Sabah, M., Mancini, G., Dellamonica, P. (2005). In vitro selection of mutants of Streptococcus pneumoniae resistant to macrolides and linezolid: relationship with susceptibility to penicillin G or macrolides. J Antimicrob Chemother 56: 633-642 [Abstract] [Full Text]  
  • Nagiec, E. E., Wu, L., Swaney, S. M., Chosay, J. G., Ross, D. E., Brieland, J. K., Leach, K. L. (2005). Oxazolidinones Inhibit Cellular Proliferation via Inhibition of Mitochondrial Protein Synthesis. Antimicrob. Agents Chemother. 49: 3896-3902 [Abstract] [Full Text]  
  • Wolter, N., Smith, A. M., Farrell, D. J., Schaffner, W., Moore, M., Whitney, C. G., Jorgensen, J. H., Klugman, K. P. (2005). Novel Mechanism of Resistance to Oxazolidinones, Macrolides, and Chloramphenicol in Ribosomal Protein L4 of the Pneumococcus. Antimicrob. Agents Chemother. 49: 3554-3557 [Abstract] [Full Text]  
  • Xaplanteri, M. A., Andreou, A., Dinos, G. P., Kalpaxis, D. L. (2003). Effect of polyamines on the inhibition of peptidyltransferase by antibiotics: revisiting the mechanism of chloramphenicol action. Nucleic Acids Res 31: 5074-5083 [Abstract] [Full Text]  
  • Colca, J. R., McDonald, W. G., Waldon, D. J., Thomasco, L. M., Gadwood, R. C., Lund, E. T., Cavey, G. S., Mathews, W. R., Adams, L. D., Cecil, E. T., Pearson, J. D., Bock, J. H., Mott, J. E., Shinabarger, D. L., Xiong, L., Mankin, A. S. (2003). Cross-linking in the Living Cell Locates the Site of Action of Oxazolidinone Antibiotics. J. Biol. Chem. 278: 21972-21979 [Abstract] [Full Text]  
  • Humphrey, W. R., Shattuck, M. H., Zielinski, R. J., Kuo, M.-S. T., Biermacher, J. J., Smith, D. P., Jensen, J. L., Schaadt, R. D., Zurenko, G. E., Richards, I. M. (2003). Pharmacokinetics and Efficacy of Linezolid in a Gerbil Model of Streptococcus pneumoniae-Induced Acute Otitis Media. Antimicrob. Agents Chemother. 47: 1355-1363 [Abstract] [Full Text]  
  • Bobkova, E. V., Yan, Y. P., Jordan, D. B., Kurilla, M. G., Pompliano, D. L. (2003). Catalytic Properties of Mutant 23 S Ribosomes Resistant to Oxazolidinones. J. Biol. Chem. 278: 9802-9807 [Abstract] [Full Text]  
  • Mc Dermott, P. F., Walker, R. D., White, D. G. (2003). Antimicrobials: Modes of Action and Mechanisms of Resistance. International Journal of Toxicology 22: 135-143 [Abstract]  
  • Moellering, R. C. Jr. (2003). Linezolid: The First Oxazolidinone Antimicrobial. ANN INTERN MED 138: 135-142 [Abstract] [Full Text]  
  • Karlowsky, J. A., Kelly, L. J., Critchley, I. A., Jones, M. E., Thornsberry, C., Sahm, D. F. (2002). Determining Linezolid's Baseline In Vitro Activity in Canada Using Gram-Positive Clinical Isolates Collected prior to Its National Release. Antimicrob. Agents Chemother. 46: 1989-1992 [Abstract] [Full Text]  
  • Aoki, H., Ke, L., Poppe, S. M., Poel, T. J., Weaver, E. A., Gadwood, R. C., Thomas, R. C., Shinabarger, D. L., Ganoza, M. C. (2002). Oxazolidinone Antibiotics Target the P Site on Escherichiacoli Ribosomes. Antimicrob. Agents Chemother. 46: 1080-1085 [Abstract] [Full Text]  
  • Zhou, C. C., Swaney, S. M., Shinabarger, D. L., Stockman, B. J. (2002). 1H Nuclear Magnetic Resonance Study of Oxazolidinone Binding to Bacterial Ribosomes. Antimicrob. Agents Chemother. 46: 625-629 [Abstract] [Full Text]  
  • Slatter, J. G., Stalker, D. J., Feenstra, K. L., Welshman, I. R., Bruss, J. B., Sams, J. P., Johnson, M. G., Sanders, P. E., Hauer, M. J., Fagerness, P. E., Stryd, R. P., Peng, G. W., Shobe, E. M. (2001). Pharmacokinetics, Metabolism, and Excretion of Linezolid following an Oral Dose of [14C]Linezolid to Healthy Human Subjects. Drug Metab. Dispos. 29: 1136-1145 [Abstract] [Full Text]  
  • Cottagnoud, P., Gerber, C. M., Acosta, F., Cottagnoud, M., Neftel, K., Tauber, M. G. (2000). Linezolid against penicillin-sensitive and -resistant pneumococci in the rabbit meningitis model. J Antimicrob Chemother 46: 981-985 [Abstract] [Full Text]  
  • Xiong, L., Kloss, P., Douthwaite, S., Andersen, N. M., Swaney, S., Shinabarger, D. L., Mankin, A. S. (2000). Oxazolidinone Resistance Mutations in 23S rRNA of Escherichia coli Reveal the Central Region of Domain V as the Primary Site of Drug Action. J. Bacteriol. 182: 5325-5331 [Abstract] [Full Text]  
  • Fines, M., Leclercq, R. (2000). Activity of linezolid against Gram-positive cocci possessing genes conferring resistance to protein synthesis inhibitors. J Antimicrob Chemother 45: 797-802 [Abstract] [Full Text]  
  • McNicholas, P. M., Najarian, D. J., Mann, P. A., Hesk, D., Hare, R. S., Shaw, K. J., Black, T. A. (2000). Evernimicin Binds Exclusively to the 50S Ribosomal Subunit and Inhibits Translation in Cell-Free Systems Derived from both Gram-Positive and Gram-Negative Bacteria. Antimicrob. Agents Chemother. 44: 1121-1126 [Abstract] [Full Text]  
  • Schülin, T., Thauvin-Eliopoulos, C., Moellering, R. C. Jr., Eliopoulos, G. M. (1999). Activities of the Oxazolidinones Linezolid and Eperezolid in Experimental Intra-Abdominal Abscess Due to Enterococcus faecalis or Vancomycin-Resistant Enterococcus faecium. Antimicrob. Agents Chemother. 43: 2873-2876 [Abstract] [Full Text]  
  • Kallia-Raftopoulos, S., Kalpaxis, D. L. (1999). Slow Sequential Conformational Changes in Escherichia coli Ribosomes Induced by Lincomycin: Kinetic Evidence. Mol. Pharmacol. 56: 1042-1046 [Abstract] [Full Text]  
  • Noskin, G. A., Siddiqui, F., Stosor, V., Hacek, D., Peterson, L. R. (1999). In Vitro Activities of Linezolid against Important Gram-Positive Bacterial Pathogens Including Vancomycin-Resistant Enterococci. Antimicrob. Agents Chemother. 43: 2059-2062 [Abstract] [Full Text]  
  • Cynamon, M. H., Klemens, S. P., Sharpe, C. A., Chase, S. (1999). Activities of Several Novel Oxazolidinones against Mycobacterium tuberculosis in a Murine Model. Antimicrob. Agents Chemother. 43: 1189-1191 [Abstract] [Full Text]  
  • Jones, M. E., Visser, M. R., Klootwijk, M., Heisig, P., Verhoef, J., Schmitz, F.-J. (1999). Comparative Activities of Clinafloxacin, Grepafloxacin, Levofloxacin, Moxifloxacin, Ofloxacin, Sparfloxacin, and Trovafloxacin and Nonquinolones Linozelid, Quinupristin-Dalfopristin, Gentamicin, and Vancomycin against Clinical Isolates of Ciprofloxacin-Resistant and -Susceptible Staphylococcus aureus Strains. Antimicrob. Agents Chemother. 43: 421-423 [Abstract] [Full Text]  
  • Swaney, S. M., Aoki, H., Ganoza, M. C., Shinabarger, D. L. (1998). The Oxazolidinone Linezolid Inhibits Initiation of Protein Synthesis in Bacteria. Antimicrob. Agents Chemother. 42: 3251-3255 [Abstract] [Full Text]  
  • Murray, R. W., Schaadt, R. D., Zurenko, G. E., Marotti, K. R. (1998). Ribosomes from an Oxazolidinone-Resistant Mutant Confer Resistance to Eperezolid in a Staphylococcus aureus Cell-Free Transcription-Translation Assay. Antimicrob. Agents Chemother. 42: 947-950 [Abstract] [Full Text]  
  • Patel, U., Yan, Y. P., Hobbs, F. W. Jr., Kaczmarczyk, J., Slee, A. M., Pompliano, D. L., Kurilla, M. G., Bobkova, E. V. (2001). Oxazolidinones Mechanism of Action: Inhibition of the First Peptide Bond Formation. J. Biol. Chem. 276: 37199-37205 [Abstract] [Full Text]